科研级 Otilimab, Anti-CSF2 Recombinant Antibody, Research Grade Otilimab
Molecular Name
Otilimab
Size
1mg, 5mg
CAS Number
1638332-55-4
Isotype
IgG1 Lambda
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
CSF2/GM-CSF[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Otilimab (development codes MOR103 and GSK3196165) is a fully human antibody which has been developed by the biotechnology company MorphoSys. It can also be referred to as HuCAL antibody, HuCAL standing for Human Combinatorial Antibody Library and being a technology used to generate monoclonal antibodies.